The DTG-SWITCH Study: Longitudinal Analysis of Virologic Failure and Drug Resistance at and After Switching to Dolutegravir-based First-line ART
Clinical trial NCT04612452 · COMPLETED
Trial details
- NCT number
- NCT04612452
- Sponsor
- University of Bern
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-11-05
- Primary completion
- 2023-03-22
- Enrollment
- 2820
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.